QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Phase III Randomized AUGMENT Study of Lenalidomide/Rituximab vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma 会议论文 作者:  Gribben, J.;  Trneny, M.;  Izutsu, K.;  Fowler, N. H.;  Hong, X. 收藏  |  浏览/下载：22/0  |  提交时间：2019/12/05 follicular lymphoma  indolent lymphoma  lenalidomide  marginal zone lymphoma  NHL  rituximab   Responses and Cardiotoxicity with R-CDOP and R-CHOP Observed in Frontline Therapy for Patients with Primary Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Randomized Phase-IV Study from Multiple Centers in China 会议论文 60th Annual Meeting of the American-Society-of-Hematology (ASH), DEC 01-04, 2018 作者:  Feng, Lili;  Chu, Xiaoxia;  Zhao, Hongguo;  Wang, Yili;  Li, Jie 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/31 Rituximab-Induced Acute Thrombocytopenia in a Patient with Relapsed Follicular Lymphoma 会议论文 60th Annual Meeting of the American-Society-of-Hematology (ASH), DEC 01-04, 2018 作者:  Jiang Yujie;  Na Wang;  Dai Yuan;  Qu, Huiting;  Feng, Lili 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/31 Identification of Patient Subgroups Demonstrating Longer Progression-Free Survival (PFS) Benefit with Bortezomib-Rituximab Versus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma (FL): Biomarker Analyses of the Phase 3 LYM3001 Study 会议论文 作者:  Coiffier, Bertrand;  Li, Weimin;  Henitz, Erin D.;  Karkera, J. D.;  Favis, Reyna 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19 A Phase 3 Trial Comparing Bortezomib Plus Rituximab with Rituximab Alone In Patients with Relapsed, Rituximab-Naive or -Sensitive, Follicular Lymphoma 会议论文 作者:  Coiffier, Bertrand;  Osmanov, Evgenii;  Hong, Xiaonan;  Scheliga, Adriana;  Mayer, Jiri 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19